A.R.T. Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-33,279
| Closed | -$132K | – | 1545 |
|
|
2019
Q1 | $132K | Buy |
33,279
+9,993
| +43% | +$39.6K | 0.01% | 1143 |
|
|
2018
Q4 | $93K | Buy |
23,286
+164
| +0.7% | +$655 | 0.01% | 1171 |
|
|
2018
Q3 | $159K | Buy |
23,122
+5,300
| +30% | +$36.4K | 0.01% | 1230 |
|
|
2018
Q2 | $120K | Buy |
+17,822
| New | +$120K | ﹤0.01% | 1282 |
|
|
2017
Q4 | – | Sell |
-36,021
| Closed | -$222K | – | 1581 |
|
|
2017
Q3 | $222K | Buy |
36,021
+5,059
| +16% | +$31.2K | 0.01% | 1102 |
|
|
2017
Q2 | $287K | Sell |
30,962
-21,338
| -41% | -$198K | 0.02% | 1017 |
|
|
2017
Q1 | $485K | Sell |
52,300
-1,100
| -2% | -$10.2K | 0.02% | 817 |
|
|
2016
Q4 | $446K | Buy |
+53,400
| New | +$446K | 0.03% | 800 |
|
|
2016
Q3 | – | Sell |
-38,433
| Closed | -$190K | – | 1012 |
|
|
2016
Q2 | $190K | Buy |
+38,433
| New | +$190K | 0.01% | 1119 |
|
|
2016
Q1 | – | Sell |
-95,877
| Closed | -$898K | – | 1571 |
|
|
2015
Q4 | $898K | Buy |
+95,877
| New | +$898K | 0.04% | 617 |
|
|
2015
Q3 | – | Sell |
-67,399
| Closed | -$1.42M | – | 1517 |
|
|
2015
Q2 | $1.42M | Buy |
67,399
+8,307
| +14% | +$175K | 0.05% | 596 |
|
|
2015
Q1 | $2.48M | Buy |
+59,092
| New | +$2.48M | 0.09% | 313 |
|